医学
粘膜切除术
内科学
胃肠病学
外科
随机对照试验
不利影响
结肠镜检查
内窥镜检查
结直肠癌
癌症
作者
Heiko Pohl,Douglas K. Rex,Jeremy Barber,Matthew T. Moyer,B. Joseph Elmunzer,Amit Rastogi,Stuart R. Gordon,Eugene Zolotarevsky,John M. Levenick,Harry R. Aslanian,Mazen Elatrache,Daniel von Renteln,Michael B. Wallace,Bhaumik Brahmbhatt,Rajesh N. Keswani,Nikhil A. Kumta,Douglas K. Pleskow,Zachary L. Smith,Mouhanna K. Abu Ghanimeh,Stephen Simmer
出处
期刊:Gut
[BMJ]
日期:2025-05-19
卷期号:: gutjnl-335075
标识
DOI:10.1136/gutjnl-2025-335075
摘要
Background Complications of endoscopic mucosal resection (EMR) of large colorectal polyps remain a concern. Objective We aimed to compare safety and efficacy of cold EMR (without electrocautery) to hot EMR (with electrocautery) of large colorectal polyps. Design In this multicentre randomised trial, patients with any large (≥20 mm) non-pedunculated colon polyp were assigned to cold or hot EMR (primary intervention), and to submucosal injection with a viscous or non-viscous solution (secondary intervention) following a 2×2 design. The primary outcome was the rate of severe adverse events (SAEs). The secondary outcome was polyp recurrence. In this study, we report results of the primary intervention. Results 660 patients were randomised and analysed. An SAE was observed in 2.1% of patients in the cold EMR group and in 4.3% in the hot EMR group (p=0.10) (per protocol analysis 1.4 vs 5.0%, p=0.017) with fewer perforations following cold EMR (0%) compared with hot EMR (1.6%, p=0.028). Postprocedure bleeding did not differ (1.5% vs 2.2%, p=0.57). The effect of cold resection was independent of the type of submucosal injection solution, polyp size or antithrombotic medications. Recurrence was detected in 27.6% and 13.6% in the cold and hot EMR groups, respectively (p<0.001). Recurrence was not significantly different for 20–29 mm polyps (18.6% vs 13.4%, p=0.24) and for sessile serrated polyps (14.1% vs 8.5%, p=0.33). Conclusion Universal application of cold EMR did not significantly lower SAEs (unless cold EMR could be completed) and doubled the recurrence rate compared with hot EMR. Trial registration details ClinicalTrials.gov, number: NCT03865537 .
科研通智能强力驱动
Strongly Powered by AbleSci AI